Clinical Trial Update: Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study of SYN006 HFA MDI given orally to healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SYN006 HFA MDI

Snippet

Sponsor: Intech Biopharm Ltd. | Conditions: Asthma | Phase 1 | Status: COMPLETED